vTv Therapeutics Announces 2020 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Initiation of Mechanistic Study of TTP399 expected during Q1 2021 Announcement of First-Patient First-Visit in…
Initiation of Mechanistic Study of TTP399 expected during Q1 2021 Announcement of First-Patient First-Visit in…
EWING, N.J., Feb. 24, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Acquires Tetramer Shop; Reveals Details on Upcoming Products PLEASANTON, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE)…
-Broad advancement of clinical pipeline- -Three-arm Phase 2 study of praluzatamab ravtansine (CX-2009) launched in…
– Data demonstrate that ImmTOR has the potential to enhance transgene expression in the liver…
ERYTECH to Participate in Upcoming Virtual Investor Conferences in March Lyon (France) and Cambridge, MA…
Fourth Quarter Highlights: Consolidated Net Revenue of $13.8 Million Up 10% vs. Third Quarter of…
Achieved Oxbryta® (voxelotor) net revenues of $41.3 million in the fourth quarter and $123.8 million for…
JERSEY, Channel Islands, Feb. 24, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics…
REDWOOD CITY, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life…
SEATTLE, Feb. 24, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a…
— NUZYRA Generated Net U.S. Sales of $12.4 Million in the Fourth Quarter 2020; a…
– G1’s COSELA™ (trilaciclib) Approved by FDA as First and Only Therapy to Decrease the…
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — Vaxart, Inc., a clinical-stage biotechnology…
JENA, Germany, Feb. 24, 2021 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical…
Daix (France), February 24, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
– Product revenues of $476 million for full year 2020, $110 million for the fourth…
Company to Host Webcast to Discuss Proof-of-Concept Data for Encaleret in Autosomal Dominant Hypocalcemia Type…
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — Pan-Biome Pharmaceuticals, Inc, a Vancouver based…
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that a patent application related to NanoZolid®…